Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | August 2021

A Complex Case of Recurrent Acute Pulmonary Embolism

Moderator: Aditya Sharma, MD;
Panelists: Riyaz Bashir, MD; Linda M. Harris, MD, FACS, DFSVS; and Srini Tummala, MD

evt | Article | July 2019

Panel Discussion: Putting Recent DVT Trial Data Into Context and Practice

Experts discuss the main takeaways of key trials in deep venous thrombosis therapy, nuances in their designs and data, whether the results have affected referrals, and more.

With Riyaz Bashir, MD, FACC, RVT; Rabih Chaer, MD, MSc; Rick de Graaf, MD, PhD; Mitchell J. Silver, DO, FACC, FSVM; and Brooke Spencer, MD, FSIR

evt | Article | January 2024

Balloon Pulmonary Angioplasty in CTEPH and CTEPD: Where Is This All Going?

BPA is a promising therapeutic option for inoperable CTEPH, a highly disabling consequence of PE; however, randomized controlled trials are needed to assess its ultimate benefits.

By Riyaz Bashir, MD, FACC, RVT; William R. Auger, MD, FCCP; and Kenneth Rosenfield, MD, MHCDS

evt | News | January 22, 2024

Thrombolex RESCUE II Study Begins Patient Enrollment

January 22, 2024—Thrombolex, Inc. announced the enrollment of the first patient in the RESCUE II study using the company’s Bashir endovascular catheter for the treatment of acute intermediate-risk pulmonary embolism (PE).

Advertisement

Advertisement

evt | News | July 2, 2020

NIH Grant Funds RESCUE Trial of Thrombolex Bashir Catheter

July 2, 2020—Thrombolex Inc. has announced that it was awarded a $3 million Small Business Innovation Research (SBIR) Direct-to-Phase II grant from the National Heart, Lung and Blood Institute (NHLBI) section of the National Institutes of Health to fund the company’s pivotal RESCUE trial under an investigational device exemption.

evt | News | May 15, 2019

Thrombolex Receives FDA Clearance for Bashir Endovascular Catheters

May 13, 2019—Thrombolex, Inc. announced FDA 510(k) clearance for the Bashir endovascular catheter (BEC) and the Bashir N-X endovascular catheter (BEC N-X).

evt | News | October 24, 2023

Thrombolex Bashir Catheter Analyzed for Acute Intermediate-Risk PE Patients in RESCUE

October 24, 2023—Thrombolex, Inc., a Pennsylvania-based medical device company focused on the treatment of arterial and venous thromboembolic diseases, announced the publication of an independent core-lab data analysis of 107 patients with acute intermediate-risk pulmonary embolism (PE) treated with the company’s Bashir endovascular catheter and small doses of recombinant tissue plasminogen activator (r-tPA) at 18 sites in the United States.

evt | Article | August 2021

Meeting the Challenge

By John A. Kaufman, MD

evt | Article | July 2019

Addressing the Unknowns of Venous Care

By Raghu Kolluri, MS, MD, RVT, FSVM, and Manjit Gohel, MD, MBChB, FRCS, FEBVS

evt | News | June 25, 2019

Study Evaluates Placement of Inferior Vena Cava Filters Before Bariatric Surgery

June 26, 2019—Findings from a nationwide observational study of prophylactic inferior vena cava filters (IVCFs) placed before bariatric surgery were published by Satyajit Reddy, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions (2019;12:1153–1160).

evt | Article | January 2024

Pulmonary Embolism Interventions

By Akhilesh K. Sista, MD, FSIR, FAHA

evt | News | July 28, 2019

Thrombolex Begins Early Feasibility and Safety Study of the Bashir Endovascular Catheter for PE

July 29, 2019—Thrombolex, Inc. announced the enrollment of the first patient in the early feasibility and safety study investigating the company's Bashir endovascular catheter for the treatment of submassive pulmonary embolism (PE).


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button